About Bruce Keyt
Bruce Keyt is an executive officer, director and promoter at MultiValent Biotherapies.
Bruce Keyt reports to the SEC as an officer of 1 public company: IGM Biosciences (IGMS).
Bruce Keyt first appears on SEC filings in 2019.
Experience
This experience comes from Bruce Keyt's profile and from SEC filings. For roles taken from filings, the years are when the filings name Bruce Keyt in the role, so the role may have started earlier or lasted longer.
MultiValent Biotherapies, Inc. Current
Chief Scientific Officer (2024 – Present)
Director
2024 – Present · Los Altos, CA
Develops targeted drug therapies for people with cancer.
II
IGM Biosciences, Inc.
Chief Scientific Officer
2011 – 2024 · Public company (IGMS)
Key Colleagues at Startups
The people Bruce Keyt works with at each company, as listed on that company's latest Form D.
MultiValent Biotherapies, Inc. · Form D, Mar 2, 2026
FS
Fred Schwarzer
Executive officer, director and promoter
SS
Stephen Snowdy
Executive officer, director and promoter
DS
Deborah Schwarzer
Chief Legal Officer and director